Switzerland
  • Europe
    • FR
    • DE
    • IT
    • ES
    • BE
    • NL
    • LU
    • DK
    • PL
    • UK
  • Switzerland
    • Basel
    • Bern
    • Geneva
    • Lausanne
    • Zürich
  • Schweiz
  • Suisse
  • Alps
  • Business
    • ABB
    • Chubb
    • Glencore
    • Nestlé
    • Novartis
    • Roche
    • UBS
    • Vitol
    • Zurich Insurance
  • NATO
  • US
  • Africa
  • Afrique

Categories

  • ABB
  • Alps
  • Basel
  • Bern
  • Chubb
  • Geneva
  • Glencore
  • Lausanne
  • Nestlé
  • Novartis
  • Roche
  • Switzerland
  • UBS
  • Vitol
  • Zürich
  • Zurich Insurance
Switzerland
  • Europe
    • FR
    • DE
    • IT
    • ES
    • BE
    • NL
    • LU
    • DK
    • PL
    • UK
  • Switzerland
    • Basel
    • Bern
    • Geneva
    • Lausanne
    • Zürich
  • Schweiz
  • Suisse
  • Alps
  • Business
    • ABB
    • Chubb
    • Glencore
    • Nestlé
    • Novartis
    • Roche
    • UBS
    • Vitol
    • Zurich Insurance
  • NATO
  • US
  • Africa
  • Afrique

Browsing Tag

NVIDIA

47 posts
RRoche
NVIDIA GTC 2026: Agentic AI Inflection Hits Healthcare and Life Sciences
Read More

NVIDIA GTC 2026: Agentic AI Inflection Hits Healthcare and Life Sciences

  • 2026-04-29
CEO Jensen Huang delivering the NVIDIA GTC 2026 keynote [Nvidia] SAN JOSE – Nvidia CEO Jensen Huang foresees the computer giant’s revenue to surpass a whopping $1 trillion…
RRoche
Roche ramps up AI computing capacity with Nvidia chip expansion
Read More

Roche ramps up AI computing capacity with Nvidia chip expansion

  • 2026-04-29
BERLIN, March 16 (Reuters) – Swiss drugmaker Roche said on Monday it had expanded its ‌artificial intelligence computing…
UUBS
UBS Upgrades Biogen to Buy With a $225 Target: Are the Next 12 Months a Pipeline Catalyst Parade?
Read More

UBS Upgrades Biogen to Buy With a $225 Target: Are the Next 12 Months a Pipeline Catalyst Parade?

  • 2026-04-22
Biogen (BIIB) stock got an upgrade to Buy from UBS with a $225 price target, citing upcoming BIIB080…
UUBS
24/7 Wall St
Read More

UBS Hikes Bloom Energy’s Price Target From $170 to $251 on the 800 VDC Data Center Revolution

  • 2026-04-21
Gorodenkoff / Shutterstock.com Quick Read UBS analyst Manav Gupta raised Bloom Energy (BE) price target to $251 from…
RRoche
Roche claims pharma’s largest GPU footprint at NVIDIA's flagship GTC event
Read More

Roche claims pharma’s largest GPU footprint at NVIDIA’s flagship GTC event

  • 2026-04-20
In May 2024, Recursion Pharmaceuticals unveiled BioHive-2, a 504-GPU supercomputer it called the largest in the pharmaceutical industry.…
UUBS
Huaqin’s US$580 million Hong Kong share sale attracts JPMorgan and UBS
Read More

Huaqin’s US$580 million Hong Kong share sale attracts JPMorgan and UBS

  • 2026-04-15
Shanghai-listed Huaqin, one of the world’s largest consumer electronics original design manufacturers (ODMs), kicked off a Hong Kong…
UUBS
Huaqin’s US$580 million Hong Kong share sale attracts JPMorgan and UBS
Read More

Huaqin’s US$580 million Hong Kong share sale attracts JPMorgan and UBS

  • 2026-04-15
Shanghai-listed Huaqin, one of the world’s largest consumer electronics original design manufacturers (ODMs), kicked off a Hong Kong…
UUBS
Yesterday’s Selloff Was Just the Beginning?
Read More

Yesterday’s Selloff Was Just the Beginning?

  • 2026-04-10
UBS downgraded ServiceNow (NOW) from Buy to Neutral with a $100 price target, citing concern that autonomous AI…
RRoche
2 Minute Medicine
Read More

Roche and NVIDIA deploy the pharmaceutical industry’s largest artificial intelligence factory

  • 2026-04-08
1. Roche has launched one of the largest artificial intelligence infrastructures in the pharmaceutical industry, powered by over…
UUBS
UBS ESG ETF Approaches Key Technical Threshold
Read More

UBS ESG ETF Approaches Key Technical Threshold

  • 2026-04-05
Low-cost ESG ETF surges on tech concentration, led by NVIDIA. Analysis of key holdings, TER of 0.10%, and…
RRoche
Roche Launches New ‘AI Factory’ To Speed Drug Development
Read More

Roche Launches New ‘AI Factory’ To Speed Drug Development

  • 2026-03-30
Aviv Regev, head of Genentech research and early development Richard Morgenstein 2021It’s the latest example of a pharmaceutical…
RRoche
Roche speeds up drug development and doubles down on Nvidia – Matthew Griffin
Read More

Roche speeds up drug development and doubles down on Nvidia – Matthew Griffin

  • 2026-03-27
Matthew Griffin is a multi-award winning Futurist and expert in Disruption and Innovation, Geopolitics, Leadership, and Technology, who…
Switzerland
www.europesays.com